| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An interdisciplinary approach to evaluating the need for assistive technology reduces equipment abandonment
|
Verza, R
|
|
2006
|
12 |
1 |
p. 88-93
|
artikel
|
| 2 |
Author Index
|
|
|
2006
|
12 |
1 |
p. S229-S243
|
artikel
|
| 3 |
Azathioprine myelosuppression in multiple sclerosis: characterizing thiopurine methyltransferase polymorphisms
|
Frohman, E M
|
|
2006
|
12 |
1 |
p. 108-111
|
artikel
|
| 4 |
Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1
|
Gilli, F
|
|
2006
|
12 |
1 |
p. 47-57
|
artikel
|
| 5 |
Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis
|
Nocentini, U
|
|
2006
|
12 |
1 |
p. 77-87
|
artikel
|
| 6 |
Core hypothermia in multiple sclerosis: case report with magnetic resonance imaging localization of a thalamic lesion
|
Linker, R A
|
|
2006
|
12 |
1 |
p. 112-115
|
artikel
|
| 7 |
Crossed aphasia in multiple sclerosis
|
Demirkiran, M
|
|
2006
|
12 |
1 |
p. 116-119
|
artikel
|
| 8 |
Demographic and health-related factors associated with complementary and alternative medicine (CAM) use in multiple sclerosis
|
Shinto, L
|
|
2006
|
12 |
1 |
p. 94-100
|
artikel
|
| 9 |
Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis
|
Kallmann, B A
|
|
2006
|
12 |
1 |
p. 58-65
|
artikel
|
| 10 |
Editorial
|
Thompson, Alan
|
|
2006
|
12 |
1 |
p. 1-1
|
artikel
|
| 11 |
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with NAb
|
Barbero, P
|
|
2006
|
12 |
1 |
p. 72-76
|
artikel
|
| 12 |
HLA-DPB1*0501 is not uniquely associated with opticospinal multiple sclerosis in Japanese patients. Important role of DPB1*0301
|
Fukazawa, T
|
|
2006
|
12 |
1 |
p. 19-23
|
artikel
|
| 13 |
Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients
|
smail, D Ben
|
|
2006
|
12 |
1 |
p. 101-103
|
artikel
|
| 14 |
Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis
|
Fainardi, E
|
|
2006
|
12 |
1 |
p. 2-12
|
artikel
|
| 15 |
Letter to the Editor
|
Gerlach, Raquel F
|
|
2006
|
12 |
1 |
p. 120-120
|
artikel
|
| 16 |
Measuring and evaluating interferon b-induced antibodies in patients with multiple sclerosis
|
Ross, C
|
|
2006
|
12 |
1 |
p. 39-46
|
artikel
|
| 17 |
No association of apolipoprotein E ε4 genotype with faster progression or less recovery of relapses in a Spanish cohort of multiple sclerosis
|
Sedano, M J
|
|
2006
|
12 |
1 |
p. 13-18
|
artikel
|
| 18 |
No effect of intravenous immunoglobulins on cytokine-producing lymphocytes in secondary progressive multiple sclerosis
|
Petereit, H F
|
|
2006
|
12 |
1 |
p. 66-71
|
artikel
|
| 19 |
Oral Presentations
|
|
|
2006
|
12 |
1 |
p. S1-S228
|
artikel
|
| 20 |
The effect of consent guidelines on a multiple sclerosis register
|
Ford, Helen L
|
|
2006
|
12 |
1 |
p. 104-107
|
artikel
|
| 21 |
The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics
|
Minden, S L
|
|
2006
|
12 |
1 |
p. 24-38
|
artikel
|
Tijdschrift beschrijving